Publications by authors named "Maria Grazia Fabbrini"
Anticancer Res
August 2014
Article Synopsis
- The study aimed to assess the safety and effectiveness of radio-chemotherapy with temozolomide in glioblastoma patients aged over 65.
- The research involved 40 patients (20 males and 20 females) with a mean age of 71.2 years, all having a Karnofsky performance status above 70 and no significant health issues.
- Results showed that toxicity levels were comparable to younger patients, with median progression-free survival of 10.6 months and overall survival of 19.3 months, supporting the treatment's viability in this older demographic.
